ACOG
Alpha Cognition Inc. Common Stock
Price Chart
Latest Quote
$5.82
| Previous Close | $5.91 |
| Open | $5.90 |
| Day High | $6.03 |
| Day Low | $5.55 |
| Volume | 45,518 |
Stock Information
| Shares Outstanding | 21.77M |
| Cash Equivalents | $54.25M |
| Revenue | $10.83M |
| Net Income | $-25.42M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $126.73M |
| EPS (TTM) | $-1.39 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $72.48M |
| Sales | $10.83M |
| Income | $-25.42M |
| Book/sh | $2.64 |
| Cash/sh | $2.49 |
| Employees | 71 |
Financial Ratios
| Quick Ratio | 10.66 |
| Current Ratio | 12.64 |
Returns & Margins
| ROA | -29.01% |
| ROE | -51.74% |
| Gross Margin | 87.52% |
| Operating Margin | -229.11% |
| Profit Margin | -234.84% |
Ownership
| Insider Ownership | 6.55% |
| Institutional Ownership | 53.20% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -13.33 |
| P/S | 11.71 |
| P/B | 2.21 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $14.67 |
Technical Indicators
| SMA20 | $5.92 |
| SMA50 | $6.13 |
| SMA200 | $6.39 |
| RSI | 44.51 |
| ATR | 0.3161 |
| Shares Float | 12.12M |
| Short Float | 1.09% |
| Short Ratio | 4.36 |
| Rel Volume | 1.26 |
Performance History
| Week | -5.98% |
| Month | -8.78% |
| Quarter | +0.52% |
| 6 Months | +0.17% |
| YTD | -10.46% |
| Year | -39.22% |
| 10 Years | +2.11% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $5.82 | 45,518 |
| 2026-06-04 | $5.91 | 19,100 |
| 2026-06-03 | $6.08 | 5,400 |
| 2026-06-02 | $6.18 | 15,000 |
| 2026-06-01 | $6.34 | 21,300 |
| 2026-05-29 | $6.19 | 113,300 |
| 2026-05-28 | $5.94 | 19,300 |
| 2026-05-27 | $5.73 | 32,200 |
| 2026-05-26 | $5.88 | 16,500 |
| 2026-05-22 | $5.85 | 29,300 |
| 2026-05-21 | $5.82 | 23,700 |
| 2026-05-20 | $5.89 | 46,100 |
| 2026-05-19 | $5.80 | 15,600 |
| 2026-05-18 | $5.75 | 61,400 |
| 2026-05-15 | $6.02 | 96,100 |
| 2026-05-14 | $5.68 | 37,100 |
| 2026-05-13 | $5.95 | 45,900 |
| 2026-05-12 | $5.49 | 59,900 |
| 2026-05-11 | $5.95 | 8,700 |
| 2026-05-08 | $6.10 | 11,700 |
| 2026-05-07 | $6.09 | 5,400 |
| 2026-05-06 | $6.38 | 32,200 |
About Alpha Cognition Inc. Common Stock
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.
đ° Latest News
Alpha Cognition Inc. (NASDAQ:ACOG) Just Reported, And Analysts Assigned A US$16.00 Price Target
Simply Wall St. âĸ 2026-05-17T13:29:32ZAlpha Cognition Inc. Common Stock Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-15T12:30:00ZAlpha Cognition Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T22:10:34ZAlpha Cognition Inc. (ACOG) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-14T21:50:02ZAlpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Zacks âĸ 2026-05-07T14:00:07ZAlpha Cognition Inc.'s (NASDAQ:ACOG) Path To Profitability
Simply Wall St. âĸ 2026-04-19T12:45:16ZAlpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-04-02T13:03:00ZAlpha Cognition (ACOG) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-04-01T12:59:32ZAlpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary
Moby âĸ 2026-03-27T12:30:00ZAlpha Cognition Q4 Earnings Call Highlights
MarketBeat âĸ 2026-03-26T21:48:58ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,915,323 | $0 | - | - |
| Cost Of Revenue | $1,915,323 | $0 | - | - |
| Total Revenue | $10,220,275 | $0 | $0 | $0 |
| Operating Revenue | $10,220,275 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $32,799,869 | $11,548,636 | $9,617,813 | $13,465,624 |
| Other Income Expense | $10,349 | $-3,401,755 | $-4,075,356 | $1,521,881 |
| Other Non Operating Income Expenses | $-77,806 | $-237,048 | - | - |
| Net Non Operating Interest Income Expense | $1,899,370 | $161,664 | $-70,489 | $-170,955 |
| Operating Expense | $30,884,546 | $11,548,636 | $9,617,813 | $13,465,624 |
| Other Operating Expenses | $-81,095 | $-463,881 | $-260,503 | $509,860 |
| Selling And Marketing Expense | $1,812,762 | $120,973 | $19,791 | $31,733 |
| General And Administrative Expense | $27,226,335 | $7,889,912 | $4,890,073 | $4,016,266 |
| Interest Expense | - | $185,777 | $77,293 | $172,880 |
| Total Other Finance Cost | - | $459,360 | - | - |
| Interest Expense Non Operating | - | $185,777 | $77,293 | $172,880 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Net Interest Income | $1,899,370 | $161,664 | $-70,489 | $-170,955 |
| Interest Income | $1,899,370 | $161,664 | $6,804 | $1,925 |
| Normalized Income | $-20,758,030 | $-11,624,020 | $-9,688,302 | $-13,636,579 |
| Net Income From Continuing And Discontinued Operation | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Total Operating Income As Reported | $-22,660,689 | $-12,012,517 | $-9,938,093 | - |
| Net Income Common Stockholders | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Net Income | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Net Income Including Noncontrolling Interests | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Net Income Continuous Operations | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Pretax Income | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Interest Income Non Operating | $1,899,370 | $161,664 | $6,804 | $1,925 |
| Operating Income | $-22,579,594 | $-11,548,636 | $-9,617,813 | $-13,465,624 |
| Depreciation Amortization Depletion Income Statement | $58,572 | $81,220 | $84,479 | $90,923 |
| Depreciation And Amortization In Income Statement | $58,572 | $81,220 | $84,479 | $90,923 |
| Amortization Of Intangibles Income Statement | $21,546 | $79,875 | $82,376 | $82,376 |
| Depreciation Income Statement | $37,026 | $1,345 | $2,103 | $8,547 |
| Gross Profit | $8,304,952 | $0 | - | - |
| Special Income Charges | - | $-39,166 | $0 | $-5,506 |
| Per Share | ||||
| Diluted EPS | $-1.18 | $-2.04 | $-3.84 | $-4.50 |
| Basic EPS | $-1.18 | $-2.04 | $-3.84 | $-4.50 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-22,609,177 | $-8,302,709 | $-9,526,530 | $-13,372,776 |
| Total Unusual Items | $88,155 | $-3,164,707 | $-4,075,356 | $1,521,881 |
| Total Unusual Items Excluding Goodwill | $88,155 | $-3,164,707 | $-4,075,356 | $1,521,881 |
| Reconciled Depreciation | $58,572 | $81,220 | $84,479 | $90,923 |
| EBITDA (Bullshit earnings) | $-22,521,022 | $-11,467,416 | $-13,601,886 | $-11,850,895 |
| EBIT | $-22,579,594 | $-11,548,636 | $-13,686,365 | $-11,941,818 |
| Diluted Average Shares | $17,681,429 | $7,247,864 | $3,585,440 | $2,718,887 |
| Basic Average Shares | $17,680,597 | $7,247,864 | $3,585,440 | $2,718,887 |
| Diluted NI Availto Com Stockholders | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Gain On Sale Of Security | $88,155 | $-3,164,707 | $-4,075,356 | $1,527,387 |
| Amortization | $21,546 | $79,875 | $82,376 | $82,376 |
| Research And Development | $1,867,972 | $3,920,412 | $4,883,973 | $8,816,842 |
| Selling General And Administration | $29,039,097 | $8,010,885 | $4,909,864 | $4,047,999 |
| Other Gand A | $7,142,360 | $5,522,832 | $1,473,992 | $1,386,429 |
| Salaries And Wages | $20,083,975 | $2,367,080 | $3,416,081 | $2,629,837 |
| Impairment Of Capital Assets | - | $39,166 | $0 | $5,506 |
| Provision For Doubtful Accounts | - | $55,000 | $0 | - |
| Other Special Charges | - | - | $18,489 | - |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $62,138,752 | $38,681,858 | $-5,235,705 | $-1,934,563 |
| Total Assets | $79,730,235 | $50,736,938 | $2,452,170 | $2,950,951 |
| Total Non Current Assets | $719,963 | $485,760 | $533,731 | $618,210 |
| Goodwill And Other Intangible Assets | $391,423 | $412,969 | $532,010 | $614,386 |
| Other Intangible Assets | $391,423 | $412,969 | $532,010 | $614,386 |
| Current Assets | $79,010,272 | $50,251,178 | $1,918,439 | $2,332,741 |
| Current Deferred Assets | $223,096 | $0 | - | - |
| Restricted Cash | $58,400 | $17,872 | $90,413 | $0 |
| Prepaid Assets | $3,119,823 | $818,537 | $266,280 | $249,045 |
| Inventory | $5,123,496 | $615,133 | $0 | - |
| Receivables | $4,438,668 | $253,426 | $157,586 | $0 |
| Other Receivables | $202,532 | $253,426 | $100,036 | - |
| Accounts Receivable | $4,236,136 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $66,046,789 | $48,546,210 | $1,404,160 | $2,083,696 |
| Cash And Cash Equivalents | $66,046,789 | $48,546,210 | $1,404,160 | $2,083,696 |
| Other Non Current Assets | - | $45,714 | - | - |
| Loans Receivable | - | $0 | $57,550 | $0 |
| Other Current Assets | - | - | $366,316 | $249,045 |
| Cash Financial | - | - | $1,404,160 | $2,083,696 |
| Debt | ||||
| Total Debt | - | $911,463 | $1,211,463 | $1,211,463 |
| Current Debt And Capital Lease Obligation | - | $911,463 | $1,211,463 | $1,211,463 |
| Current Debt | - | $911,463 | $1,211,463 | $1,211,463 |
| Other Current Borrowings | - | $911,463 | $1,211,463 | $1,211,463 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $17,200,060 | $11,642,111 | $7,155,865 | $4,271,128 |
| Total Non Current Liabilities Net Minority Interest | $8,069,985 | $8,291,359 | $4,539,872 | $214,284 |
| Other Non Current Liabilities | $47,181 | $102,783 | $84,125 | $8,295 |
| Derivative Product Liabilities | $7,986,860 | $8,188,576 | $4,455,747 | $205,989 |
| Non Current Deferred Liabilities | $35,944 | $0 | - | - |
| Current Liabilities | $9,130,075 | $3,350,752 | $2,615,993 | $4,056,844 |
| Current Deferred Liabilities | $153,171 | $0 | $10,413 | $0 |
| Payables And Accrued Expenses | $8,976,904 | $2,439,289 | $1,394,117 | $2,294,721 |
| Payables | $3,067,616 | $872,676 | $475,553 | $2,016,057 |
| Accounts Payable | $3,067,616 | $872,676 | $475,553 | $2,016,057 |
| Current Notes Payable | - | - | $1,220,372 | $1,211,463 |
| Equity | ||||
| Common Stock Equity | $62,530,113 | $39,094,765 | $-4,703,757 | $-1,320,177 |
| Preferred Stock Equity | $62 | $62 | $62 | $62 |
| Total Equity Gross Minority Interest | $62,530,175 | $39,094,827 | $-4,703,695 | $-1,320,177 |
| Stockholders Equity | $62,530,175 | $39,094,827 | $-4,703,695 | $-1,320,177 |
| Gains Losses Not Affecting Retained Earnings | $-104,301 | $-104,301 | $-104,301 | $8,407,731 |
| Other Equity Adjustments | $-104,301 | $-104,301 | $-104,301 | $8,407,731 |
| Retained Earnings | $-97,106,775 | $-76,436,900 | $-61,648,173 | $-49,986,851 |
| Other | ||||
| Ordinary Shares Number | $21,742,104 | $16,019,787 | $4,728,359 | $2,720,938 |
| Share Issued | $21,742,104 | $16,019,787 | $4,728,359 | $2,720,938 |
| Tangible Book Value | $62,138,690 | $38,681,796 | $-5,235,767 | $-1,934,563 |
| Invested Capital | $62,530,113 | $40,006,228 | $-3,492,294 | $-108,714 |
| Working Capital | $69,880,197 | $46,900,426 | $-697,554 | $-1,724,103 |
| Total Capitalization | $62,530,175 | $39,094,827 | $-4,703,695 | $-1,320,177 |
| Additional Paid In Capital | $25,849,516 | $16,507,736 | $17,288,430 | - |
| Capital Stock | $133,891,735 | $99,128,292 | $39,760,349 | $40,258,943 |
| Common Stock | $133,891,673 | $99,128,230 | $39,760,287 | $40,258,943 |
| Preferred Stock | $62 | $62 | $62 | $62 |
| Non Current Deferred Revenue | $35,944 | $0 | - | - |
| Current Deferred Revenue | $153,171 | $0 | $10,413 | $0 |
| Current Accrued Expenses | $5,909,288 | $1,566,613 | $918,564 | $278,664 |
| Net PPE | $328,540 | $27,077 | $1,721 | $3,824 |
| Gross PPE | $328,540 | $27,077 | $12,370 | $3,824 |
| Other Properties | $328,540 | $27,077 | $12,370 | $3,824 |
| Finished Goods | $672,700 | $0 | - | - |
| Work In Process | $725,460 | $615,133 | $0 | - |
| Raw Materials | $3,725,336 | $0 | $0 | - |
| Accumulated Depreciation | - | $-11,994 | $-10,649 | - |
| Construction In Progress | - | $18,000 | $0 | - |
| Pensionand Other Post Retirement Benefit Plans Current | - | - | $791,280 | $550,660 |
| Dueto Related Parties Current | - | - | - | - |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-20,673,856 | $-7,782,355 | $-8,799,565 | $-9,246,526 |
| Operating Activities | ||||
| Operating Cash Flow | $-20,380,367 | $-7,755,654 | $-8,799,565 | $-9,241,650 |
| Cash Flow From Continuing Operating Activities | $-20,380,367 | $-7,755,654 | $-8,799,565 | $-9,241,650 |
| Operating Gains Losses | $-70,155 | $3,164,707 | $4,085,284 | $-1,823,444 |
| Investing Activities | ||||
| Capital Expenditure | $-293,489 | $-26,701 | - | $-4,876 |
| Investing Cash Flow | $-293,489 | $-26,701 | $0 | $-4,876 |
| Cash Flow From Continuing Investing Activities | $-293,489 | $-26,701 | $0 | $-4,876 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $34,321,975 | $56,541,384 | $9,223,587 | $0 |
| Financing Cash Flow | $38,214,963 | $54,851,864 | $8,230,015 | $24,785 |
| Cash Flow From Continuing Financing Activities | $38,214,963 | $54,851,864 | $8,230,015 | $24,785 |
| Net Other Financing Charges | $-2,506,693 | $-6,236,320 | $-965,572 | - |
| Net Common Stock Issuance | $34,321,975 | $56,541,384 | $9,223,587 | $0 |
| Common Stock Issuance | $34,321,975 | $56,541,384 | $9,223,587 | $0 |
| Cash Dividends Paid | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-911,463 | $-300,000 | $-55,000 | $0 |
| Issuance Of Debt | $0 | $4,545,000 | $0 | - |
| Interest Paid Supplemental Data | $4,894 | $37,754 | $59,777 | $16,000 |
| End Cash Position | $66,105,189 | $48,564,082 | $1,494,573 | $2,083,696 |
| Beginning Cash Position | $48,564,082 | $1,494,573 | $2,083,696 | $11,301,793 |
| Changes In Cash | $17,541,107 | $47,069,509 | $-569,550 | $-9,221,741 |
| Proceeds From Stock Option Exercised | $7,311,144 | $301,800 | $27,000 | $40,785 |
| Net Issuance Payments Of Debt | $-911,463 | $4,245,000 | $-55,000 | $0 |
| Net Long Term Debt Issuance | $-911,463 | $4,245,000 | $-55,000 | $0 |
| Long Term Debt Payments | $-911,463 | $-300,000 | $-55,000 | $0 |
| Long Term Debt Issuance | $0 | $4,545,000 | $0 | - |
| Net PPE Purchase And Sale | $-293,489 | $-26,701 | $0 | $-4,876 |
| Purchase Of PPE | $-293,489 | $-26,701 | $0 | $-4,876 |
| Change In Working Capital | $-4,618,883 | $-241,679 | $-1,568,535 | $2,730,088 |
| Change In Other Working Capital | $95,535 | - | - | - |
| Change In Payables And Accrued Expense | $6,520,855 | $1,045,172 | $-1,451,264 | $2,110,301 |
| Change In Payable | $6,520,855 | $1,045,172 | $-1,451,264 | $2,110,301 |
| Change In Account Payable | $6,520,855 | $1,045,172 | $-1,451,264 | $2,110,301 |
| Change In Prepaid Assets | $-2,490,774 | $-671,718 | $-117,271 | $619,787 |
| Change In Inventory | $-4,508,363 | $-615,133 | $0 | - |
| Change In Receivables | $-4,236,136 | $0 | - | - |
| Changes In Account Receivables | $-4,236,136 | $0 | - | - |
| Other Non Cash Items | $-2,551 | $2,802,998 | $-6,720 | $168,168 |
| Stock Based Compensation | $4,922,525 | $1,131,661 | $2,369,585 | $1,701,807 |
| Provisionand Write Offof Assets | $0 | $55,000 | $0 | - |
| Asset Impairment Charge | $0 | $39,166 | $0 | $5,506 |
| Depreciation Amortization Depletion | $58,572 | $81,220 | $84,479 | $90,923 |
| Depreciation And Amortization | $58,572 | $81,220 | $84,479 | $90,923 |
| Gain Loss On Investment Securities | $-88,155 | $3,164,707 | $4,085,284 | $-1,823,444 |
| Gain Loss On Sale Of PPE | $18,000 | $0 | - | - |
| Net Income From Continuing Operations | $-20,669,875 | $-14,788,727 | $-13,763,658 | $-12,114,698 |
| Effect Of Exchange Rate Changes | - | $0 | $-19,573 | $3,644 |
| Income Tax Paid Supplemental Data | - | - | $0 | $0 |
| Interest Paid Cff | - | - | $-70,777 | $-16,000 |
| Amortization Cash Flow | - | - | $82,376 | $82,376 |
| Amortization Of Intangibles | - | - | $82,376 | $82,376 |
| Depreciation | - | - | $2,103 | $8,547 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
| Change In Tax Payable | - | - | - | - |
| Change In Income Tax Payable | - | - | - | - |